In further experiments, we treated HeLa cells with LY294002 (an AKT inhibitor) and U0126 (an ERK1/2 inhibitor), and the results showed that both LY294002 and U0126 abolished the promoting effect of SULF2 on the growth of cervical cancer cells. This evidence concerns the gene AKT1 and cervical cancer.